IRIS
PISATURO, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.833
NA - Nord America 5.114
AS - Asia 4.739
SA - Sud America 789
Continente sconosciuto - Info sul continente non disponibili 341
AF - Africa 78
OC - Oceania 4
Totale 21.898
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.565
US - Stati Uniti d'America 5.000
SG - Singapore 1.726
IE - Irlanda 1.293
CN - Cina 860
HK - Hong Kong 798
BR - Brasile 656
VN - Vietnam 587
DE - Germania 421
IT - Italia 415
UA - Ucraina 318
GB - Regno Unito 315
KR - Corea 216
JP - Giappone 157
IN - India 131
FI - Finlandia 106
SE - Svezia 89
TR - Turchia 83
GR - Grecia 77
FR - Francia 65
AR - Argentina 58
CA - Canada 52
BD - Bangladesh 37
AT - Austria 29
IQ - Iraq 29
PL - Polonia 27
ZA - Sudafrica 27
NL - Olanda 23
MX - Messico 21
CO - Colombia 18
PK - Pakistan 18
ES - Italia 17
ID - Indonesia 16
BE - Belgio 15
EC - Ecuador 14
VE - Venezuela 13
MA - Marocco 10
CZ - Repubblica Ceca 9
IR - Iran 9
JM - Giamaica 9
PE - Perù 8
RS - Serbia 8
AL - Albania 7
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
LT - Lituania 7
UY - Uruguay 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
DZ - Algeria 6
EU - Europa 6
HN - Honduras 6
PA - Panama 6
TN - Tunisia 6
KZ - Kazakistan 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
IL - Israele 4
KG - Kirghizistan 4
PH - Filippine 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
SN - Senegal 4
BB - Barbados 3
CM - Camerun 3
GE - Georgia 3
GT - Guatemala 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CD - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
Totale 21.551
Salva come PNG Salva come JPEG
Città #
Moscow 2.748
Dublin 1.293
Hong Kong 792
Santa Clara 784
Singapore 706
San Jose 567
Jacksonville 478
Chandler 438
Ashburn 348
Seoul 214
Ho Chi Minh City 180
Bremen 178
Princeton 176
Hanoi 149
Roxbury 146
New York 127
Cambridge 119
Beijing 112
Hefei 112
Dallas 109
The Dalles 82
Ann Arbor 73
Caserta 72
Bengaluru 68
Munich 68
Los Angeles 65
São Paulo 64
Medford 58
Boardman 55
Memphis 48
Wilmington 46
Da Nang 45
Orem 45
Naples 44
Woodbridge 39
San Mateo 33
Washington 29
Des Moines 26
Haiphong 24
Warsaw 23
Nuremberg 22
Chennai 21
Biên Hòa 20
Frankfurt am Main 19
Milan 19
Helsinki 18
Nanjing 18
Council Bluffs 17
London 17
Mountain View 16
Rio de Janeiro 16
Tokyo 16
Brasília 15
Brussels 15
Montreal 15
Napoli 15
San Francisco 15
Vienna 15
Johannesburg 14
Jinan 13
Manchester 13
Rome 13
Tianjin 13
Amsterdam 12
Curitiba 12
Düsseldorf 12
Hillsboro 12
Atlanta 11
Brooklyn 11
Campinas 11
Denver 11
Houston 11
Hải Dương 11
Istanbul 11
Mumbai 11
Porto Alegre 11
Stockholm 11
Belo Horizonte 10
Changsha 10
Chicago 10
Toronto 10
Brno 9
Bến Tre 9
Guangzhou 9
Paris 9
Shanghai 9
Auburn Hills 8
Aversa 8
Boston 8
Grafing 8
Phoenix 8
Shenyang 8
Thái Bình 8
Zhengzhou 8
Caxias do Sul 7
Hangzhou 7
Kingston 7
Lappeenranta 7
Nairobi 7
New Delhi 7
Totale 11.507
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 209
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 206
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 194
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 187
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 180
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 177
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 177
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 166
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 166
Absence of occult HCV infection in patients experiencing an immunodepression condition 165
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 164
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 162
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 161
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 160
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 151
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 151
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 151
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 150
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 150
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 149
Absence of occult HCV infection in HIV-positive patients 145
Clinical and virological characteristics associated with severe acute hepatitis B 140
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 139
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 139
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 139
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 138
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 138
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 137
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 136
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 135
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 134
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 132
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms 131
F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis 131
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 130
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 130
Epidemiology and management of hepatitis C virus infections in immigrant populations 130
A HIGH GENETIC HETEROGENEITY IN HBsAg CAN AFFECT IMMUNOGENICITY IN ACUTE HEPATITIS B INFECTION 129
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 128
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 127
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 127
Absence of occult HCV infection in HIV-positive patients 126
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 125
Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn 124
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy 124
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 124
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 123
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 123
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 123
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 122
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 122
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 122
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 121
Virological factors associated with failure to the latest generation of direct acting agents (Daa) and re-treatment strategy: A narrative review 121
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 120
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic 119
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 119
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 118
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 118
Characterization of hepatitis virus co-infections in a cohort of immigrants living in southern Italy 118
Role of genetic polymorphisms in hepatitis C virus chronic infection 117
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 116
Occult HBV infection in the oncohematological setting. 116
Clinical and virological characteristics associated with severe acute hepatitis B 116
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 115
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 115
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 114
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 114
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 114
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 114
Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. 113
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 113
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 113
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 113
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 113
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 112
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 112
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 111
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 111
An update on the treatment options for HBV/HCV coinfection 111
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 110
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 109
Pharmacotherapies for multidrug-resistant gram-positive infections: current options and beyond 109
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 109
The association between education level and chronic liver disease of any etiology 108
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index 108
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 107
Role of occult hepatitis B virus infection in chronic hepatitis C 107
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 106
Management of HBV reactivation in non-oncological patients 106
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature 105
Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report 105
Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. 105
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 105
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 104
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B 104
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 104
Totale 13.107
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022878 0 15 2 8 210 13 104 11 23 83 66 343
2022/20232.137 193 56 27 115 299 127 2 102 1.126 15 37 38
2023/2024985 68 23 73 68 350 116 15 26 10 11 48 177
2024/20253.141 9 39 14 86 475 439 387 295 527 456 234 180
2025/202612.683 499 594 649 608 1.079 7.033 673 436 462 293 227 130
2026/2027184 77 107 0 0 0 0 0 0 0 0 0 0
Totale 21.898